Vice President and Head of Global PK/PD and Pharmacometrics
Eli Lilly and Company
Indianapolis, Indiana, United States
Dr. Gemma Louise Dickinson joined Eli Lilly and Company in 2008 as a Research Scientist in the Global PK/PD organization at Erl Wood, UK. She later moved to Indianapolis, where she became Director of Mechanistic Pharmacokinetics and Computational ADME. In 2022, she returned to PK/PD and now serves as Vice President and Head of Global PK/PD and Pharmacometrics, overseeing PK/PD deliverables across the portfolio with teams in the US, UK, Singapore, and Ireland.
A recognized expert in mechanistic pharmacokinetics, Dr. Dickinson holds a bachelor’s degree in Pharmacology and a PhD in Pharmacokinetics from The University of Sheffield. She is passionate about advocating for women in science and mentoring women and girls in STEM.
Disclosure information not submitted.
Is Pharmacometrics limited by the industry settings?
Wednesday, November 13, 2024
1:45 PM – 3:15 PM MST
Wednesday, November 13, 2024
1:45 PM – 3:15 PM MST